(Q57351083)

English

Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases

scientific article published on 01 September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

0 references

1 reference

based on heuristic

inferred from title

Martin Klabusay

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Vera Sukova

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Petr Coupek

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Yvona Brychtova

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jiri Mayer

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 September 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Cytometry Part B: Clinical Cytometry

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

72

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

363-370

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Structure of the CAMPATH-1 antigen, a glycosylphosphatidylinositol-anchored glycoprotein which is an exceptionally good target for complement lysis

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

21 January 2018

High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

A pilot study of alemtuzumab (anti-CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy-refractory peripheral T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Early prediction of outcome and response to alemtuzumab therapy in chronic lymphocytic leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibody-based therapies for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Campath-1 Abs 'in the bag' for hematological malignancies: the Cape Town experience

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of alemtuzumab in nonmyeloablative hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary structure of CD52.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

The CAMPATH-1 antigen (CDw52)

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Subcutaneous CAMPATH-1H in fludarabine-resistant/relapsed chronic lymphocytic and B-prolymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

CD52 expression in Waldenstrom's macroglobulinemia: implications for alemtuzumab therapy and response assessment.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of CD52 on plasma cells in plasma cell proliferative disorders

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Terminology and nomenclature for standardization in quantitative fluorescence cytometry.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of cell surface markers during differentiation of CD34+, CD38-/lo fetal and adult bone marrow cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling of CD34+ cells identifies a molecular signature of chronic myeloid leukemia blast crisis.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

CD52 expression in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

CD52 expression in hairy cell leukemia.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood cell preparation influences the level of expression of leukocyte cell surface markers as assessed with quantitative multicolor flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Mantle cell lymphoma in Taiwan: Clinicopathological and molecular study of 21 cases including one cyclin D1-negative tumor expressing cyclin D2

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20181

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CYTO.B.20181

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17428002%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57351083&oldid=2172545540"